NEW YORK – Diagnostic firm Meridian Bioscience is taking the step forward from just making consumables for other firms developing tests for detecting SARS-CoV-2 to developing its first test for the coronavirus.
It is also partnering to distribute a test developed by another firm.
During the past eight months or so of the COVID-19 pandemic Meridian's involvement in that space has largely been manufacturing reagents and consumables for other firms' SARS-CoV-2 tests, including qPCR chemistries and enzyme master mixes.